Skip to content
MedBiz Pro

e-mail: info@medbizpro.com
  • News
  • Blog Zone
  • Contact
  • sr
MedBiz Pro > Oglasi > Izdaje se lokal u prizemlju u naselju Bulbulder na Zvezdari, nedaleko

Izdaje se lokal u prizemlju u naselju Bulbulder na Zvezdari, nedaleko

Posted on 07/07/201807/07/2018 by Mila

Izdaje se lokal na dva nivoa u naselju Braće Jerković. Struktura je podeljena na dva nivoa,  donji je oko 18m2, a gornji je 36m2 i gore je open space i toalet.  https://www.youtube.com/watch?v=9BEzF_aHjNk 

Više informacija: http://frame.goglasi.com/frame?eid=162441320&q=apoteku

 

Posted in Oglasi
Post navigation
Ustupam razrađenu apoteku, Kragujevac →
← Led reklama za apoteku

News

  • Why Beans Are a Natural Superfood
    on 14/09/2024 at 1:00 pm

    SATURDAY, Sept. 14, 2024 -- Beans may sometimes give you gas, but one expert says that shouldn't stop you from finding ways to include them in your diet.Why? Because they are packed with nutrients that contribute to good health.“Beans are in a u...

  • Antibody-drug conjugate shows promise in treating ovarian and endometrial cancers
    on 14/09/2024 at 10:33 am

    Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial and cervical cancers who gain clinically meaningful benefit from adding immunotherapy to current standard treatments, while a first-in-human study found 'promising' antitumor activity with a novel antibody drug conjugate (ADC) targeting the protein claudin 6 in heavily pretreated patients with ovarian and endometrial cancers.

  • NIH funds new research to combat emerging viruses
    on 14/09/2024 at 10:02 am

    Albert Einstein College of Medicine has received a five-year, $14 million per year grant from the National Institute of Allergy and Infectious Diseases (NIAID) to participate in a broad national effort to develop "plug-and-play" vaccines and antibody-based therapies against a wide range of emerging viruses. The grant is part of NIAID's new Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network, which was announced earlier today.

  • UCL researchers develop UK's first national menopause education program
    on 14/09/2024 at 9:49 am

    Details of two new courses to help individuals before and during the menopause have been published as part of the launch of the UK's first menopause education and support programme, created by UCL researchers

  • New research network focuses on high-priority viruses
    on 14/09/2024 at 9:43 am

    The National Institutes of Health (NIH) has established a pandemic preparedness research network to conduct research on high-priority pathogens most likely to threaten human health with the goal of developing effective vaccines and monoclonal antibodies. Currently, many of the diseases caused by these pathogens have no available vaccines or therapeutics, and investing in this research is key to preparing for potential public health crises-;both in the United States and around the world. NIH's National Institute of Allergy and Infectious Diseases (NIAID) expects to commit approximately $100 million per year to fund the program, pending the availability of funds.

  • Study reveals challenges of distinguishing autism from BPD
    on 14/09/2024 at 8:45 am

    Conducted through interpretive phenomenological analysis, the study involved one-to-one, semi-structured interviews with 10 participants. Each participant recounted unnoticed autistic traits from childhood and described the pervasive impact of a BPD misdiagnosis. The study highlights the challenges of distinguishing between autism and BPD, especially among autistic women, who often face misdiagnosis.

  • Key enzyme identified as potential target for cancer treatment
    on 14/09/2024 at 8:23 am

    During every moment of any living organism's life, enzymes are at work. These crucial proteins support life through most biological processes, including metabolism, movement, respiration, and digestion.

  • New cancer drug shows encouraging results in Phase I/II trial
    on 14/09/2024 at 8:17 am

    The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated a manageable safety profile consistent with similar ADCs and initial efficacy in heavily pretreated patients with advanced or metastatic solid tumors, according to interim data shared today at the 2024 European Society for Medical Oncology (ESMO) Congress by researchers from The University of Texas MD Anderson Cancer Center.

  • Innovative heart valve technology could improve patient lives
    on 14/09/2024 at 8:03 am

    Now, a team of UBC Okanagan researchers believe they have found a way to harness the strengths of both technologies in a way that could be life-changing-;and life-saving-;for many. Dr. Hadi Mohammadi and his fellow researchers in the Heart Valve Performance Laboratory at UBC Okanagan are focused on developing the mechanical heart valves of the future.

  • Researchers seek early Alzheimer's detection with MRSI
    on 14/09/2024 at 7:51 am

    University of Virginia professor Mathews Jacob has secured a $3.9 million grant to advance his innovative research on detecting Alzheimer's disease in its early stages. Jacob, who specializes in electrical and computer engineering, is teaming up with researchers from the University of Iowa and the University of California-San Francisco to push the boundaries of imaging technology that tracks the brain's metabolic changes -; offering a fresh perspective on studying neurodegenerative disorders.

  • Study identifies common misuses of spike-in normalization
    on 14/09/2024 at 7:44 am

    Researchers at University of California San Diego have published new guidelines that could help scientists significantly improve their results when quantifying the interactions between DNA and proteins. Understanding these interactions is critical to our understanding of human biology in general, and can also help scientists develop new treatments for a wide range of diseases, including many cancers.

  • Development and validation of a prognostic nomogram for esophageal cancer patients based on SEER Asian population
    on 14/09/2024 at 12:00 am
  • Understanding the rationales and information environments for early, late, and nonadopters of the COVID-19 vaccine
    on 14/09/2024 at 12:00 am
  • HIF-2α-dependent induction of miR-29a restrains TH1 activity during T cell dependent colitis
    on 14/09/2024 at 12:00 am
  • COVID-19 vaccine refusal is driven by deliberate ignorance and cognitive distortions
    on 14/09/2024 at 12:00 am
  • The neuroscience of itch in relation to transdiagnostic psychological approaches
    on 14/09/2024 at 12:00 am
  • Consistent FFP2-masking as part of reducing viral respiratory infections on medical wards for allogeneic hematopoietic stem cell transplantation
    on 14/09/2024 at 12:00 am
  • Steatotic liver disease associated with 2,4-dienoyl-CoA reductase 1 deficiency
    on 14/09/2024 at 12:00 am
  • Single-cell sequencing analysis of multiple myeloma heterogeneity and identification of new theranostic targets
    on 14/09/2024 at 12:00 am
  • Ejaculatory function after radiotherapy for prostate cancer: a systematic review and meta-analysis
    on 14/09/2024 at 12:00 am
Theme by Out the Box
  • News
  • Blog Zone
  • Contact